Faculty profile

Sidney Kennedy

ResearcherPsychiatryUniversity of Toronto

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.

Sidney Kennedy

Researcher

Psychiatry

Health Sciences

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
6 publications in the last five years, latest in 2025.
Principal investigator on 3 research grants (3 CIHR), most recently in 2022.
Supervised 2 trainees who won CIHR awards, most recently in 2017.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

288

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Functional Electrical Stimulation Major Depressive Disorder Pilot Trial Randomized Controlled Trial Biomarkers Major Depression Neuroimaging

Latest papers

Sustained mood improvement with laughing gas exposure (SMILE): a randomised, placebo-controlled pilot trial of nitrous oxide for treatment-resistant depression.
BJPsych open · 2025
A Phase 2 Randomized Trial of NBI-1065846 (TAK-041) in Patients With Anhedonia Associated With Major Depressive Disorder: Results of the TERPSIS Study.
Journal of clinical psychopharmacology · 2025
Generalizability of Treatment Outcome Prediction Across Antidepressant Treatment Trials in Depression.
JAMA network open · 2025

All 17 publications

Latest funding

MIRA for Adaptive CLinical Evaluation in Depression (MIRACLE-D): Design and Evaluation of an AI-Powered Personalized Virtual Assistant for Depression Care
CIHR · 2026 · Co-investigator
$100,000
Investigating the efficacy of a novel therapy for suicide risk in adults: A randomized controlled trial of an intensive single session of "Brief Skills for Safer Living"
CIHR · 2024 · Co-investigator
$1,204,875
Intravenous Ketamine versus Personalized Accelerated Brain Stimulation in Treatment-Resistant Depression: A Pilot Randomized Feasibility Trial of Rapid-Acting Treatments (IKARE-TRD)
CIHR · 2023 · Co-investigator
$608,175

All 17 grants and awards

17 publications.

Sustained mood improvement with laughing gas exposure (SMILE): a randomised, placebo-controlled pilot trial of nitrous oxide for treatment-resistant depression.

Ladha KS, Lee J, Mattina GF, Pazmino-Canizares J, Wijeysundera DN, Nezhad FG, Tassone VK, Adamsahib F, Lou W, Kennedy S, Bhat V, SMILE Study Investigators

BJPsych open2025

DOI: 10.1192/bjo.2025.10823 PMID: 40936464

A Phase 2 Randomized Trial of NBI-1065846 (TAK-041) in Patients With Anhedonia Associated With Major Depressive Disorder: Results of the TERPSIS Study.

Benedetto SR, Ionescu A, Ge T, Furey M, Lin S, Jha MK, Krystal A, Shah AA, Walling DP, Shah N, Rizvi SJ, Kennedy S, Laurenza A, Murthy V, Roberts E, Singh JB

Journal of clinical psychopharmacology2025

DOI: 10.1097/jcp.0000000000002046 PMID: 40719142

Generalizability of Treatment Outcome Prediction Across Antidepressant Treatment Trials in Depression.

Zhukovsky P, Trivedi MH, Weissman M, Parsey R, Kennedy S, Pizzagalli DA

JAMA network open2025

DOI: 10.1001/jamanetworkopen.2025.1310 PMID: 40111362

Ketamine-Assisted Psychotherapy Provides Lasting and Effective Results in the Treatment of Depression, Anxiety, and Post-Traumatic Stress Disorder at 3 and 6 Months: Findings from a Large Retrospective Effectiveness Study.

Yermus R, Bottos J, Bryson N, De Leo JA, Earleywine M, Hackenburg E, Kennedy S, Kezemidis M, Kratina S, McMaster R, Medrano B, Mina M, Morisano D, Muench M, Pillai S, Scharlach R, Setlur V, Verbora M, Wolfson E, Zaer N, Lo C

Psychedelic medicine (New Rochelle, N.Y.)2024

DOI: 10.1089/psymed.2023.0021 PMID: 40051583

Self-harm presentations to hospital trauma centre emergency departments during the first year of the COVID-19 pandemic.

Gordon M, Jayakumar N, Atzema C, Korczak DJ, Kennedy S, Schaffer A, Goldstein B, Orser BA, Yee D, Fiksenbaum L, Choi LHL, Phillips A, McFarlan A, Kreller M, Freedman C, Tanenbaum B, McDowall D, Ceniti A, Sinyor M

Psychiatry research2024

DOI: 10.1016/j.psychres.2024.115892 PMID: 38642422

Symptom dimensions of major depression in a large community-based cohort.

Wainberg M, Zhukovsky P, Hill SL, Felsky D, Voineskos A, Kennedy S, Hawco C, Tripathy SJ

Psychological medicine2023

DOI: 10.1017/s0033291721001707 PMID: 34008483

Cortisol reactivity to stress predicts behavioral responsivity to reward moderation by sex, depression, and anhedonia.

Cunningham S, Mazurka R, Wynne-Edwards KE, Milev RV, Pizzagalli DA, Kennedy S, Harkness KL

Journal of affective disorders2021

DOI: 10.1016/j.jad.2021.05.126 PMID: 34153656

Investigating correlates of athletic identity and sport-related injury outcomes: a scoping review.

Renton T, Petersen B, Kennedy S

BMJ open2021Senior author

DOI: 10.1136/bmjopen-2020-044199 PMID: 33837101

Gut microbial metabolites in depression: understanding the biochemical mechanisms

Caspani G, Kennedy S, Foster JA, Swann J

Microbial Cell2019288 citationsOpen Access

DOI: 10.15698/mic2019.10.693 PMID: W2978837562

Conflict monitoring mechanism at the single-neuron level in the human ventral anterior cingulate cortex.

Shapira-Lichter I, Strauss I, Oren N, Gazit T, Sammartino F, Giacobbe P, Kennedy S, Hutchison WD, Fried I, Hendler T, Lozano AM

NeuroImage2018

DOI: 10.1016/j.neuroimage.2018.03.028 PMID: 29551460

Something wrong or missing on this profile? Suggest a correction

Sidney Kennedy

Research

Latest papers

Latest funding

Sustained mood improvement with laughing gas exposure (SMILE): a randomised, placebo-controlled pilot trial of nitrous oxide for treatment-resistant depression.

A Phase 2 Randomized Trial of NBI-1065846 (TAK-041) in Patients With Anhedonia Associated With Major Depressive Disorder: Results of the TERPSIS Study.

Generalizability of Treatment Outcome Prediction Across Antidepressant Treatment Trials in Depression.

Ketamine-Assisted Psychotherapy Provides Lasting and Effective Results in the Treatment of Depression, Anxiety, and Post-Traumatic Stress Disorder at 3 and 6 Months: Findings from a Large Retrospective Effectiveness Study.

Self-harm presentations to hospital trauma centre emergency departments during the first year of the COVID-19 pandemic.

Symptom dimensions of major depression in a large community-based cohort.

Cortisol reactivity to stress predicts behavioral responsivity to reward moderation by sex, depression, and anhedonia.

Investigating correlates of athletic identity and sport-related injury outcomes: a scoping review.

Gut microbial metabolites in depression: understanding the biochemical mechanisms

Conflict monitoring mechanism at the single-neuron level in the human ventral anterior cingulate cortex.

Deciphering Metacognition and Treatment Response in Depression With a Novel Digital Paradigm

Social determinants of Lesbian, Gay, and Bisexual suicidality in Canada

Frequent collaborators

Peter Giacobbe

Benjamin Goldstein

Sophie Grigoriadis

Jon Barrett

Anthony Levitt

Mark Sinyor

Colin Hawco

Venkat Bhat

Clement Hamani

Ayal Schaffer

Daniel Felsky

Michael Wainberg

Peter Zhukovsky

Elaine Herer

Richard Pittini

Doreen Yee

Wendy Lou

Aristotle Voineskos

Dominique Morisano

Jane Foster

Zindel Segal

Clare Atzema